Zerbaxa Dosing Problems Result in FDA Warning
The FDA has made label changes to the antibacterial drug Zerbaxa after receiving reports of medication errors due to confusing labeling.
May 21, 2015 By: Irvin Jackson
The FDA has made label changes to the antibacterial drug Zerbaxa after receiving reports of medication errors due to confusing labeling.
A federal judge has ordered the CEO of 3M Company to attend settlement negotiations over Combat Arms earplugs hearing loss litigation.
Plaintiffs have filed a Master Complaint in consolidated hair relaxer litigation, which will help make direct filing of cases to the MDL court easier.
A federal judge has ordered parties to sift through Paraquat lawsuits to identify cases which are unlikely to move forward based on patient deaths and implausible theories of proof.